Other Assets, Noncurrent in USD of Atara Biotherapeutics, Inc. from Q4 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Atara Biotherapeutics, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2013 to Q3 2025.
  • Atara Biotherapeutics, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $881K, a 73.8% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Atara Biotherapeutics, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $881K -$2.48M -73.8% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $927K -$2.68M -74.3% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $2.84M -$1.02M -26.5% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $3.1M -$1.74M -35.9% 31 Dec 2024 10-Q 12 Nov 2025
Q3 2024 $3.36M -$2.93M -46.6% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $3.61M -$2.97M -45.1% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $3.87M -$3.04M -44% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $4.84M -$2.17M -31% 31 Dec 2023 10-K 07 Mar 2025
Q3 2023 $6.29M -$877K -12.2% 30 Sep 2023 10-Q 01 Nov 2023
Q2 2023 $6.58M -$652K -9.02% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $6.91M +$4.69M +211% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $7.02M +$4.65M +196% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $7.17M +$6.5M +970% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $7.23M +$6.54M +949% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $2.22M +$1.49M +205% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $2.37M +$1.54M +186% 31 Dec 2021 10-K 08 Feb 2023
Q3 2021 $670K -$207K -23.6% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $689K -$327K -32.2% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $729K -$268K -26.9% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 $827K +$260K +45.9% 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $877K +$611K +230% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $1.02M +$697K +218% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $997K +$461K +86% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $567K -$7K -1.22% 31 Dec 2019 10-K 01 Mar 2021
Q3 2019 $266K -$219K -45.2% 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $319K -$43K -11.9% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $536K +$436K +436% 31 Mar 2019 10-Q 09 May 2019
Q4 2018 $574K +$314K +121% 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 $485K +$385K +385% 30 Sep 2018 10-Q 06 Nov 2018
Q2 2018 $362K +$186K +106% 30 Jun 2018 10-Q 01 Aug 2018
Q1 2018 $100K -$720K -87.8% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 $260K +$158K +155% 31 Dec 2017 10-K 26 Feb 2019
Q3 2017 $100K -$2K -1.96% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $176K +$75K +74.3% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 $820K +$731K +821% 31 Mar 2017 10-Q 04 May 2017
Q4 2016 $102K -$6K -5.56% 31 Dec 2016 10-K 27 Feb 2018
Q3 2016 $102K +$4K +4.08% 30 Sep 2016 10-Q 04 Nov 2016
Q2 2016 $101K -$325K -76.3% 30 Jun 2016 10-Q 08 Aug 2016
Q1 2016 $89K +$10K +12.7% 31 Mar 2016 10-Q 06 May 2016
Q4 2015 $108K +$60K +125% 31 Dec 2015 10-K 09 Mar 2017
Q3 2015 $98K -$1.99M -95.3% 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 $426K 30 Jun 2015 10-Q 07 Aug 2015
Q1 2015 $79K 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $48K +$36K +300% 31 Dec 2014 10-K 04 Mar 2016
Q3 2014 $2.08M 30 Sep 2014 10-Q 12 Nov 2014
Q4 2013 $12K 31 Dec 2013 10-K 26 Feb 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.